Bracco Injeneering, a subsidiary of Bracco Imaging, has introduced new EmpowerCTA+, an advanced engineering contrast injection system that allows radiologic technologist to control the computed tomography suite.
The company has initially launched the EmpowerCTA+ in the US followed by Europe. It has been showcased at the European Congress of Radiology in Vienna.
The EmpowerCTA+ injector system has been developed for the vascular administration of contrast and flushing media and is used in conjunction with computed tomography scanning of the body with an optional interface to a CT scanner and an optional calculator for glomerular filtration rate.
Bracco Diagnostics president and CEO and Business Unit Injectors head Vittorio Puppo said: "We are extremely pleased to announce the availability on the market of the EmpowerCTA+.
"The contrast injector system was reengineered with digital touch technology and a new visionary design with high performance, which will help us to increase market penetration."
EmpowerCTA+ has a saline advance function that tests a patient’s patency and vein integrity while its saline jump feature minimizes the amount of contrast a patient receives.
Its optional accessory Extravasation Detection Accessory (EDA) is indicated to detect extravasations of ionic and nonionic contrast during CT procedures using a power injector.
According to the company, it is not intended for use as a long-term infusion pump, nor is it intended to be used to inject any agents other than contrast media or flushing media.
Image: The EmpowerCTA+ injector system is used in conjunction with computed tomography scanning of the body with an optional interface to a CT scanner. Photo: courtesy of renjith krishnan/ FreeDigitalPhotos.net.